AKCI
Modify Date: 2025-09-17 18:04:57
AKCI structure
|
Common Name | AKCI | ||
|---|---|---|---|---|
| CAS Number | 669750-88-3 | Molecular Weight | 369.464 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 555.9±60.0 °C at 760 mmHg | |
| Molecular Formula | C19H27N7O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 290.0±32.9 °C | |
Use of AKCIA small-molecule inhibitor that blocks the Aurora C/IκBα interaction (IC50=24.9 uM) and exerts antitumor activity in MDA-MB-231 breast cancer cells; induces G2/M cell-cycle arrest through modulation of the p53/p21/CDC2/cyclin B1 pathways, significantly inhibits MDA-MB-231 cell migration and invasion, as well as decreasing colony formation and tumor growth, decreases PMA-induced activation of NF-κB. |
| Name | 4,8-Dimethyl-N-{5-[2-(4-morpholinyl)ethyl]-1,4,5,6-tetrahydro-1,3,5-triazin-2-yl}-2-quinazolinamine |
|---|---|
| Synonym | More Synonyms |
| Description | A small-molecule inhibitor that blocks the Aurora C/IκBα interaction (IC50=24.9 uM) and exerts antitumor activity in MDA-MB-231 breast cancer cells; induces G2/M cell-cycle arrest through modulation of the p53/p21/CDC2/cyclin B1 pathways, significantly inhibits MDA-MB-231 cell migration and invasion, as well as decreasing colony formation and tumor growth, decreases PMA-induced activation of NF-κB. |
|---|---|
| References | References 1. Han EH, et al. Oncotarget. 2017 Jun 29;8(41):69691-69708. View Related Products by Target Aurora Kinase |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 555.9±60.0 °C at 760 mmHg |
| Molecular Formula | C19H27N7O |
| Molecular Weight | 369.464 |
| Flash Point | 290.0±32.9 °C |
| Exact Mass | 369.227722 |
| LogP | 0.64 |
| Vapour Pressure | 0.0±1.5 mmHg at 25°C |
| Index of Refraction | 1.684 |
| 2-Quinazolinamine, 4,8-dimethyl-N-[1,4,5,6-tetrahydro-5-[2-(4-morpholinyl)ethyl]-1,3,5-triazin-2-yl]- |
| 4,8-Dimethyl-N-{5-[2-(4-morpholinyl)ethyl]-1,4,5,6-tetrahydro-1,3,5-triazin-2-yl}-2-quinazolinamine |
| 1,3,5-triazin-2-amine, N-[(2E)-4,8-dimethyl-2(1H)-quinazolinylidene]-1,4,5,6-tetrahydro-5-[2-(4-morpholinyl)ethyl]- |